BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Catalent, Inc. Reports Third Quarter Fiscal 2022 Results

  Catalent, Inc. today announced financial results for the third quarter of fiscal 2022, which ended March 31, 2022.

  May 3, 2022

   · 

  26 min read
• Genetown

  Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Healthcare Conference

  Relay Therapeutics, Inc. is scheduled to participate in a fireside chat at the Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 3:20 p.m. PT in Las Vegas, NV.

  May 3, 2022

   · 

  1 min read
• Genetown

  Inozyme Pharma to Present at Upcoming Investor Conferences - May 03, 2022

  Inozyme Pharma, Inc. announced Axel Bolte, MSc, MBA, the company’s co-founder, president, and chief executive officer, will present at the following investor conferences:

  May 3, 2022

   · 

  1 min read
• Genetown

  Phio Pharmaceuticals Announces Trial-In-Progress Poster at ASCO 2022

  Phio Pharmaceuticals Corp. announced today that it will present a trial-in-progress poster at the 2022 American Society of Clinical Oncology (ASCO) annual meeting, which is being held June 3-7, 2022 in Chicago, IL.

  May 3, 2022

   · 

  1 min read
• Business

  Pionyr Immunotherapeutics Adds Three Leading Oncology Researchers and Drug Developers to Scientific Advisory Board

  Pionyr Immunotherapeutics, Inc. announced today that Johanna Joyce, Ph.D., Olivier Elemento, Ph.D., and Michael Quigley, Ph.D., will join Miriam Merad, Ph.D., as members of Pionyr’s Scientific Advisory Board.

  May 3, 2022

   · 

  3 min read
• Titan Medical Announces Purchase Order from Medtronic

  Titan Medical Inc. today announced receipt of a $2.6 million purchase order from Medtronic plc (NYSE: MDT), a global leader in healthcare technology.

  May 3, 2022

   · 

  4 min read
• Genetown

  Akoya to Participate at Three Upcoming Investor Conferences - May 03, 2022

  Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be participating in three upcoming investor conferences.

  May 3, 2022

   · 

  1 min read
• Biotech Bay

  89bio to Participate in Upcoming Investor Conferences in May 2022

  89bio, Inc. announced that Company’s Management will participate in the following upcoming investor conferences in May.

  May 3, 2022

   · 

  1 min read
• Business

  Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast

  Intra-Cellular Therapies, Inc. announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, May 10, 2022, to provide a corporate update and discuss details of the Company’s financial results for the quarter ended March 31, 2022.

  May 3, 2022

   · 

  1 min read
• Drug Development

  Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170.

  Umoja Biopharma, Inc. announced today the Seattle Children’s activation of the Phase 1 ENLIGHTen clinical trial in patients with osteosarcoma to assess the safety and tolerability of autologous “universal” CAR T cells when administered with UB-TT170.

  May 3, 2022

   · 

  6 min read